In 2026, the Europe Glucagon-Like Peptide-1 Agonists Market size is expected to reach USD 4.41 billion
These gutbrain interactions due to metabolites can be a potential target in treating complex behavior diseases including, autism spectrum disorder (ASD) 76, 159
We are dedicated to safe, effective weight loss and individualized care
Fortunately, the field of dermatology and aesthetic care offers a suite of Best skin lightening treatment that can help you achieve the luminous skin of your dreams
doi: 10.3389/fonc.2026.1680441 Received 06 August 2025 Revised 20 January 2026 Accepted 20 January 2026 Published 03 February 2026 Volume 16 - 2026 Edited by Arumugam Jayakumar, University of Texas MD Anderson Cancer Center, United States Reviewed by Enrico Martin, University Medical Center Utrecht, Netherlands Fei Song, Affiliated Hospital of Nantong University, China Updates Copyright 2026 Zhu, Shen, Yang, Han, Li, Xie, Tan, Lu, Ji and Zhang